期刊文献+

DCE-MRI定量参数预测高强度超声消融术治疗症状性子宫肌瘤首次体积消融率价值 被引量:25

Research on DCE-MRI Quantitative Analysis Predicts Immediate Therapeutic Response of High-Intensity Focused Ultrasound Ablation of Symptomatic Uterine Fibroids
原文传递
导出
摘要 目的探讨DCE-MRI定量渗透性与T1灌注分析预测高强度超声消融术(HIFU)治疗子宫肌瘤首次体积消融率价值。方法搜集本院29例症状性子宫肌瘤行HIFU消融治疗患者(36个肌瘤,直径3.1~9.2 cm),治疗前、后3天内分别行DCE-MRI和常规MRI检查,术前测量子宫肌瘤DCE-MRI定量参数值(K^(trans)、K_(ep)、V_e、Vp、BF、BV),术后测量肌瘤首次体积消融率,根据体积消融率划分为消融70%以上组(H组)和70%以下组(L组),回顾性分析这两组病例术前渗透性与T_1灌注定量参数值有无差别及其与体积消融率的相关性,然后采用ROC曲线评价各参数值的预测价值,寻找术前预测首次体积消融率的最佳临界值。结果 (1)H组(n=20)K^(trans)、K_(ep)、V_e、BF低于L组(n=16),差异有统计学意义(P值均<0.05),余两组各参数间无统计学差异。(2)K^(trans)、BF、BV与首次体积消融率呈负相关(r分别为-0.471、-0.452、-0.396,P值均<0.05)。(3)K^(trans)、BF、BV值预测首次体积消融率ROC曲线下面积(AUC)分别为0.803、0.809、0.750(P值均<0.05)。以体积消融率70%分界,均获得较高的敏感性和特异性。结论不同消融率组之间术前K^(trans)、K_(ep)、V_e、BF存在差异,K^(trans)、BF、BV与首次体积消融率呈负相关,即术前K^(trans)、BF、BV值越高,首次体积消融率越低,这三种参数中BF预测效能最好,K^(trans)次之。术前DCEMRI定量参数值可用于预测瘤灶的首次体积消融率,为HIFU消融治疗子宫肌瘤病例筛选和初步判断疗效提供依据。 Objective To evaluate dynamic contrastenhanced magnetic resonance imaging( DCE-MRI) parameters in the prediction of the immediate therapeutic response of high-intensity focused ultrasound( HIFU) therapy in the treatment of symptomatic uterine fibroids. Methods A total of 36 symptomatic uterine Fibroids( diameter: 3. 1- 9. 2 cm) in 29 female patients were treated with MR-HIFU therapy. All patients underwent DCE-MRI and conventional MR scan in 3 days before and after HIFU treatment. The pretreatment DCE-MRI parameters( Ktrans,Kep,Ve,Vp,BF,BV) and the post-treatment immediate non-perfused volume ratio( NPVR) were obtained respectively. We assigned the datas to NPVR 〉 70 %and NPVR 〈 70 % group,Then analyzed the differences of DCE-MRI parameters between the previous group and the correlations between the DCE-MRI parameters and NPVR retrospectively. Receiver operating characteristic( ROC) curve analyses were performed to determine which parameters were significant predictors for ablation efficacy and to seek for the optimal cutoff value. Results( 1) Ktrans,Kep,Ve,BF values of the NPVR 〉 70 % group was significantly lower than the NPVR 〈70 % group( P 〈 0. 05),No significant correlations were found between any other parameters.( 2) The immediate NPVR was negatively correlated with the Ktrans,BF,BV values( r =- 0. 471,- 0. 452 and- 0. 396 respectively; P 〈 0. 05 for all).( 3) The area under ROC curve( AUC) of the baseline Ktrans,BF,BV values used to predict the immediate NPVR were 0. 803,0. 809,0. 750 respectively( P 〈 0. 05 for all),The cutoff value of Ktrans,BF,BV provided a higher sensitivity and specificity in predicting for the ablation efficacy. Conclusion A higher Ktrans,BF,BV value deriving from pretreatment DCE-MRI suggested a poor ablation efficacy of HIFU therapy for symptomatic uterine fibroids. The BF values had the best predictive value,the Ktransvalues took second place,and the BV value was the worst. The pretreatment DCE-MRI parameters may be useful for prediction the ablation efficacy in selecting cases and evaluating the early efficacy.
出处 《临床放射学杂志》 CSCD 北大核心 2016年第4期545-550,共6页 Journal of Clinical Radiology
关键词 磁共振成像 动态增强技术 高强度超声聚焦刀 子宫肌瘤 首次体积消融率 Dynamic contrast-enhanced magnetic resonance imaging High-intensity focused ultrasound Immediate non-perfused volume ratio Fibroid
  • 相关文献

参考文献21

  • 1Lee DW, Gibson TB, Cads GS, et al. Uterine fibroid treatment pat- terns in a population of insured women[ J]. Fertil Steril,2009,91 : 566-574.
  • 2Froeling V, Meckelburg K, Scheurig-Muenkler C, et al. Midterm re- suits after uterine artery embolization versus MR-guided high-intensi- ty focused ultrasound treatment for symptomatic uterine fibroids [ J ]. Cardiovasc Intervent Radiol,2013,36 : 1508 -1513.
  • 3Chikui T, Obara M, Simonetti AW, et al. The principal of dynamic contrast enhanced MRI, the method of pharmacokinetic analysis, and its application in the head and neck region [ J ]. Int J Dent, 2012,2012:480659.
  • 4Jenne JW, Preusser T, GUnther M. High-intensity focused ultra- sound : principles, therapy guidance, simulations and applications [ J]. Z Med Phys,2012,22:311-322.
  • 5Orsini LF, Salardi S, Pilu G, et al. Pelvic organs in premenarcheal girls : real-time uhrasonography [ J ]. Radiology, 1984,153 : 113-116.
  • 6Chang H, Wang C, Tian J. Correlation between uterine fibroids with various magnetic resonance imaging features and therapeutic effects of high-intensityfocused ultrasound ablation [ J ]. Pak J Med Sci, 2015,31:869-873.
  • 7Swe TT, Onitsuka H, Kawamoto K, et al. Uterine leiomyoma: correla- tion between signal intensity on magnetic resonance imaging and pathologic characteristics[ J]. Radiat Med, 1992,10:235-242.
  • 8Kim YS, Lira HK, Kim JH, et al. Dynamic contrast-enhanced mag- netic resonance Imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids [J]. Invest Radiol, 2011,46: 639- 647.
  • 9Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of mag- netic resonance-guided focused ultrasound surgery for uterine myo- mas: from six to twelve months after volume reduction [J]. J Minim Invasive Gyneco1,2007,14:616-621.
  • 10Shimada K, Ohashi I, Kasahara I, et al. Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomy- omas[ J]. AJR,2004,182:1043-1050.

二级参考文献33

  • 1高强度聚焦超声肿瘤治疗系统临床应用指南(试行)[J].中华医学杂志,2005,85(12):796-797. 被引量:57
  • 2潘奇,王鲁,孙惠川,刘银坤,叶胜龙,汤钊猷.不同转移潜能人肝癌细胞系转录因子活性差异分析[J].中华肝脏病杂志,2006,14(1):37-40. 被引量:21
  • 3周崑,熊正爱.聚焦超声治疗子宫肌瘤的研究进展[J].中华妇产科杂志,2007,42(1):66-67. 被引量:10
  • 4[3]Goodwin SC,Vedamtham S,McLncas B,et al.Preliminary experience with uterine artery embolization for uterine fibroids.J-Vas-Interv-Radiol,1997,8:517
  • 5[4]Cornelis F,Ferrand J,Ravina JH.Embolized uterine myomata: morphologic features.Minim Invasive Ther Allied Technol,1998,7:27
  • 6[5]Ravina JH,Bouret JH,Ciraru-vigneron N,et al.Recourse to particular arterial embolization in the treatment of some uterine leiomyomas.Bull-Acad-Natl-Med,1997,181:233
  • 7[6]Ravina JH,Ciraru-Vigneron N.Pregnancy after arterial embolization of uterine myomata: preliminary results in 7 cases.Minim Invasive Ther Allied Technol,1998,7:27
  • 8Skubitz KM,Skubitz AP.Differential gene expression in uterine leiomyoma[J].J Lab Clin Med,2003,141 (5):297 -308.
  • 9Dai Y,Guo Y,Frey RR,et al.Thienopyrine Ureas as novel and potentmultitargeted receptor tyrosine kinase inhibitors[J].J Med Chem,2005,48(19):6066 -6083.
  • 10Nakayama T,Cho YC,Mine Y,et al.Expression of vascular endothelial stromal tumors,leiomyomas and schwannomas[J].World J Gastroenterol,2006,12(38):6182 -6187.

共引文献144

同被引文献181

引证文献25

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部